HeartBeam, Inc.
About HeartBeam, Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$21.0M
- Total assets
- $5.8M
- Market cap
- $46.6M
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $21.1M
- Operating income
- -$21.1M
- Income tax
- $0
- Net income
- -$21.0M
- EPS (basic)
- $-0.62
- EPS (diluted)
- $-0.62
Balance sheet
- Total assets
- $5.8M
- Current assets
- $4.7M
- Total liabilities
- $3.2M
- Current liabilities
- $3.2M
- Shareholders’ equity
- $2.6M
Cash flow
- Operating cash flow
- -$14.0M
- Investing cash flow
- -$600.0K
- Financing cash flow
- $16.6M
- Net cash flow
- $2.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $46.6M
- EPS (diluted)
- $-0.62
- Shares outstanding
- 57.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 11, 2021
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $21.0M.
- Trading 76% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review HeartBeam, Inc..
Write a review
News about HeartBeam, Inc.
News & sentiment via Polygon.io
